Pheroze Tamboli, MBBS
Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div
About Dr. Tamboli
I have been the lead pathology collaborator in most clinical and basic science trials, and numerous other funded and non-funded research protocols related to renal tumors at MD Anderson Cancer Center. I was also a member of the The Cancer Genome Atlas (TCGA) Renal Cell Carcinoma disease working group and the analysis working group.
Present Title & Affiliation
Primary Appointment
Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1989 | Dow Medical College, Karachi, PAK, MBBS, Medicine |
Postgraduate Training
| 1998-1999 | Fellowship, Surgical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1997-1998 | Fellowship, Urologic Pathology, Henry Ford Hospital, Detroit, MI |
| 1992-1997 | Residency, Anatomic and Clinical Pathology, Henry Ford Hospital, Detroit, MI |
Board Certifications
| 2002 | Anatomic Pathology, American Board of Pathology |
Experience & Service
Academic Appointments
Associate Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012
Assistant Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2000 - 2006
Faculty Associate, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1999 - 2000
Selected Publications
Abstracts
- Ebare K, Wang G, Wang Q, Nair V, Iyer S, Rao P, Tamboli P, Kannan K, Wang J, Karam J, Soleimani M, Bhat K, Sircar K. Spatial Transcriptomic Evaluation of Tumor And Tumor Microenvironment of Renal Cell Carcinoma With Respect To Regional Histology And Response To Immunotherapy. Mod Pathol 104(3):S940-42, 2024.
- Kumar G, Ruiz-Cordero R, Akgul M, Murugan P, Shen S, Brimo F, Rao P, Tamboli P , Creighton C, Bhat K, Karam J, Kannan K, Sircar K. Gene Expression Signatures From FFPE Kidney Tumor Samples Can Predict For Clinically Indolent Renal Oncocytic Tumors. Mod Pathol 104(3):S982-83, 2024.
Patient Reviews
CV information above last modified May 24, 2024